Balyasny Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.21M Buy
2024
Q4
Sell
2024
Q3
$37K Sell
2024
Q2
$70.5K Sell
2024
Q1
$148K Sell
2023
Q4
$710K Buy
2023
Q3
Sell
2023
Q2
$36.6K Buy
2022
Q3
Sell
2022
Q2
$77K Buy
2022
Q1
Sell
2021
Q4
$208K Buy